Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 149.22

-3.1%

3:49 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: NeuroInvestment who wrote (1623)	6/26/2006 2:48:29 AM
From: DewDiligence_on_SI	Read Replies (2) of 1834

Generic doxepin is available only as capsules or liquid. Patients may willingly snap a tablet in half, but measuring out half the contents of a capsule… is far less likely IMHO. I used to split 20mg Prozac capsules to save money because I was self-pay and the 10mg capsules cost almost the same amount as the 20mg ones. Perhaps this is a bad example because the half-life of Prozac is so long it didn’t make much difference if the split was imprecise. But my main point is that splitting capsules isn’t all that cumbersome if the economic incentive is there. If a generic company decides to start manufacturing a tablet, Somaxon will take that as indicating an intent to make a 'splittable' formulation as a means of poaching...and intends to sue them. This would make an interesting lawsuit to follow and handicap. Can you recall a similar case being litigated?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next